Medium materiality6/10
Revolution Medicines price target raised to $240 from $235 at Guggenheim
Why it may matterVerify against the original reporting
Bullish; upside potential supported by higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target above current price implies meaningful upside potential.
- Target $240; price $197.3; upside ~22%.
Key facts
- 01
Target: $240
- 02
Posted price: $197.3
- 03
Analyst firm: Guggenheim
- 04
Analyst: Michael Schmidt
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.